Pemazyre is used to treat adults with unresectable (inoperable) or metastatic cholangiocarcinoma (bile duct cancer) that has an FGFR2 gene fusion or rearrangement, and who have already received prior treatment.
Pemigatinib
Generic Name/API:Pemigatinib
Packaging:One bottle contains 14 tablets of Pemigatinib
Storage:Store at 20°C to 25°C
Dosage:For dosage information, please check the General Information section.
Strength:4.5mg, 9mg and 13.5mg
Indication:Pemazyre is a prescription medication used to treat certain types of bile duct cancer (cholangiocarcinoma). It belongs to a class of drugs called FGFR inhibitors, which target and block abnormal proteins that help cancer cells grow. Pemazyre is mainly used in adults whose cancer has spread or cannot be removed by surgery and has tested positive for FGFR2 gene fusions or rearrangements. It is usually given after other treatments haven’t worked, and its use requires specific genetic testing to confirm the presence of FGFR2 alterations.
Pemazyre is an oral targeted therapy used primarily for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma (bile duct cancer) that has a specific genetic alteration known as an FGFR2 (fibroblast growth factor receptor 2) fusion or rearrangement. It works by blocking the FGFR2 protein, which can promote cancer cell growth when abnormally activated. Pemazyre is typically prescribed after other treatments have failed, and its use is guided by the presence of FGFR2 alterations confirmed through genetic testing.
Strength:
4.5mg, 9mg and 13.5mg Pemigatinib tablet is available
Dosage:
- For Cholangiocarcinoma, the recommended dosage of Pemazyre is 13.5 mg orally once daily for 14 consecutive days followed by 7 days off therapy, in 21-day cycles.
- For Myeloid/lymphoid neoplasm with FGFR1 rearrangement, recommended dosage of Pemazyre is 13.5 mg orally once daily on a continuous basis.
Recommended Dose Reductions for Pemazyre for Adverse Reactions
| Dose Reduction | Recommended Dosage | |
| Cholangiocarcinoma with FGFR2 Fusion or Rearrangement | MLNs with FGFR1 Rearrangement | |
| First | 9 mg once daily for first 14 days of each 21-day cycle | 9mg once daily |
| Second | 4.5 mg once daily for first 14 days of each 21-day cycle | 4.5mg once daily |
| Third | Discontinue | 4.5 mg once daily for first 14 days of each 21-day cycle |
Adverse Reactions:
- Pemazyre can cause the retinal pigment epithelial detachment which may lead to symptoms such as blurred vision, Photopsia, dry eyes. Dose modification or discontinue the use of pemazyre as per the instructions from the doctor.
- Pemazyre can cause hyperphosphatemia, which may result in soft tissue mineralization, cutaneous calcification and calcinosis, and non-uremic calciphylaxis. Monitor phosphate levels regularly. If serum phosphate exceeds 5.5 mg/dL, begin a low-phosphate diet. For levels above 7 mg/dL, start phosphate-lowering treatment and consider withholding, reducing the dose, or permanently discontinuing Pemazyre, depending on the severity and duration of the hyperphosphatemia.
Side effects:
- Ocular Toxicity
- Hyperphosphatemia and Soft Tissue Mineralization
- Embryo-Fetal Toxicity
Storage:
Store Pemazyre tablets at 20°C to 25°C
- Pemazyre can cause Retinal pigment epithelial detachment which may include symptoms such as blurred vision, visual floaters, or photopsia.
- Pemazyre can increase phosphate levels in the blood, which may require dietary changes, phosphate-lowering therapy, or dose adjustments.
- Pemazyre can cause fetal harm therefore potential risk is associated with pregnant women.
FAQ
How is Pemazyre taken?
Pemazyre is taken orally, once daily for 14 days, followed by 7 days off, in a 21-day cycle. It should be taken around the same time each day, with or without food.
Is there a need for a special test before taking Pemazyre?
Yes, a genetic test to confirm FGFR2 fusion or rearrangement, as Pemazyre only works in cancers with this mutation.
What are the key criteria for selecting a supplier?
While selecting a supplier, we essentially ensure that the supplier holds a valid Good Distribution Practice (GDP) certification and possesses a valid operating license. These credentials confirm the supplier’s adherence to international standards for the proper distribution of medicinal products.
What is the cost of Pemazyre (Pemigatinib) tablets in India
The cost of Pemazyre (Pemigatinib) tablets in India varies as it is not locally available and must be imported. Factors such as supplier availability, import duties and currency exchange rates may impact the final price. For the latest cost details, contact 24/7QualityMeds at +91 9967979080.
How to buy Pemazyre (Pemigatinib) tablets online in India?
To buy Pemazyre (Pemigatinib) tablets online in India at a genuine price, contact 24/7QualityMeds. We provide patients with complete support in legally importing the medicine and ensure safe delivery at the best possible price.
